TIGAR and lymphoid neoplasm: In mouse models, TIGAR can support the development of intestinal (9) and lymphoid tumors (13) and in a model of pancreatic ductal adenocarcinoma (PDAC), loss of TIGAR limited the development of pancreatic premalignancies.